BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35794397)

  • 1. Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.
    Zhang E; Phan P; Algarni HA; Zhao Z
    Pharm Res; 2022 Nov; 39(11):2673-2698. PubMed ID: 35794397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.
    Nguyen PHD; Jayasinghe MK; Le AH; Peng B; Le MTN
    ACS Nano; 2023 Mar; 17(6):5187-5210. PubMed ID: 36896898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
    Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical progress and advanced research of red blood cells based drug delivery system.
    Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M; Li Y; Raza F; Liu Y; Wei Y; Rong R; Zheng M; Yuan W; Su J; Qiu M
    Biomaterials; 2021 Dec; 279():121202. PubMed ID: 34749072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies.
    Bhateria M; Rachumallu R; Singh R; Bhatta RS
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1219-36. PubMed ID: 24912015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation.
    Malhotra S; Dumoga S; Singh N
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1776. PubMed ID: 35106966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red Blood Cells as Smart Delivery Systems.
    Han X; Wang C; Liu Z
    Bioconjug Chem; 2018 Apr; 29(4):852-860. PubMed ID: 29298380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
    Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
    J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A numerical study on drug delivery
    Nikfar M; Razizadeh M; Paul R; Muzykantov V; Liu Y
    Nanoscale; 2021 Oct; 13(41):17359-17372. PubMed ID: 34590654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic Rebuilding of Multifunctional Red Blood Cells: Modular Design Using Functional Components.
    Guo J; Agola JO; Serda R; Franco S; Lei Q; Wang L; Minster J; Croissant JG; Butler KS; Zhu W; Brinker CJ
    ACS Nano; 2020 Jul; 14(7):7847-7859. PubMed ID: 32391687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
    Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
    Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte-inspired delivery systems.
    Hu CM; Fang RH; Zhang L
    Adv Healthc Mater; 2012 Sep; 1(5):537-47. PubMed ID: 23184788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
    Zelepukin IV; Yaremenko AV; Shipunova VO; Babenyshev AV; Balalaeva IV; Nikitin PI; Deyev SM; Nikitin MP
    Nanoscale; 2019 Jan; 11(4):1636-1646. PubMed ID: 30644955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers.
    Brenner JS; Mitragotri S; Muzykantov VR
    Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies.
    Chao CJ; Zhang E; Zhao Z
    Adv Drug Deliv Rev; 2023 Jun; 197():114840. PubMed ID: 37088403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation.
    Zhu K; Xu Y; Zhong R; Li W; Wang H; Wong YS; Venkatraman S; Liu J; Cao Y
    Regen Biomater; 2023; 10():rbad045. PubMed ID: 37250975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo nano-biosensing element of red blood cell-mediated delivery.
    Zhu R; Avsievich T; Popov A; Bykov A; Meglinski I
    Biosens Bioelectron; 2021 Mar; 175():112845. PubMed ID: 33262059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
    Glassman PM; Hood ED; Ferguson LT; Zhao Z; Siegel DL; Mitragotri S; Brenner JS; Muzykantov VR
    Adv Drug Deliv Rev; 2021 Nov; 178():113992. PubMed ID: 34597748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery.
    Ding Y; Lv B; Zheng J; Lu C; Liu J; Lei Y; Yang M; Wang Y; Li Z; Yang Y; Gong W; Han J; Gao C
    J Control Release; 2022 Jan; 341():702-715. PubMed ID: 34933051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery by erythrocytes: "Primum non nocere".
    Villa CH; Seghatchian J; Muzykantov V
    Transfus Apher Sci; 2016 Dec; 55(3):275-280. PubMed ID: 27856317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.